Vertex Pharmaceuticals (VRTX) Interest Coverage Ratio Growth (1y) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,150.63% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.27% |
| Sep 30, 2025 | 141.50% |
| Jun 30, 2025 | 187.63% |
| Mar 31, 2025 | 91.69% |
| Dec 31, 2024 | 292.93% |
| Sep 30, 2024 | 56.28% |
| Jun 30, 2024 | -487.40% |
| Dec 31, 2020 | 18.31% |
| Sep 30, 2020 | 610.55% |
| Jun 30, 2020 | 184.50% |
| Mar 31, 2020 | 173.66% |
| Dec 31, 2019 | 467.98% |
| Sep 30, 2019 | -37.96% |
| Jun 30, 2019 | 91.08% |
| Mar 31, 2019 | 143.89% |
| Dec 31, 2012 | -213.40% |
| Sep 30, 2012 | -100.77% |
| Mar 31, 2012 | 267.57% |
| Dec 31, 2011 | 183.09% |
| Sep 30, 2011 | 160.49% |
| Mar 31, 2011 | 67.12% |
| Dec 31, 2010 | 32.59% |
| Sep 30, 2010 | 34.33% |
| Jun 30, 2010 | 2.59% |
| Mar 31, 2010 | 15.44% |